Cirqle Biomedical Secures Pre-Seed Funding for Next Generation Contraceptive - Business Wire

Cirqle Biomedical Secures Pre-Seed Funding for Next Generation Contraceptive  Business Wire

Cirqle Biomedical today announced that it has secured $1.8M for pre-clinical development of a novel non-hormonal contraceptive technology.